Court Battles

Supreme Court asked to halt limits on mail-order abortion pill Mifepristone

Comments:

by Sophie Brams - 05/02/26 1:41 PM ET

Comments:

Link copied

by Sophie Brams - 05/02/26 1:41 PM ET

Comments:

Link copied

NOW PLAYING

A pharmaceutical company that manufactures and distributes the abortion pill Mifepristone asked the Supreme Court on Saturday to block a federal appeals court ruling prohibiting doctors from prescribing the medication through telehealth services or dispensing it through the mail.

New York-based Danco Laboratories, LLC, filed an emergency motion with the high court seeking an “immediate administrative stay” on the 5th U.S. Circuit Court of Appeals ruling while the court considers the appeal.

“The panel’s ruling injects immediate confusion and upheaval into highly time-sensitive medical decisions — and it forces Danco, [Food and Drug Administration] FDA, certified Mifeprex providers, patients, and pharmacies all to guess at what is allowed and what is not,” lawyers wrote in the filing.

A three-judge panel sided with Louisiana on Friday in a case against the Food and Drug Administration, issuing a temporary nationwide injunction that reinstates a 2021 requirement for the abortion pill to be prescribed and dispensed in person.

Developing.

Zach Schonfeld contributed.

Add as preferred source on Google